Clinical Trial

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is being conducted to evaluate the pharmacokinetics, safety, and tolerability of INCA033989 following subcutaneous (SC) or intravenous administration (IV) n healthy adult participants.
Protocol Amendment History 6 changes
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-07-09
notable Enrollment increased: 72 -> 126 participants 2026-07-09
minor Trial arms changed: 4 -> 7 2026-07-09
notable Primary completion pushed: 2026-05-23 -> 2026-10-19 2026-06-09
minor Completion pushed: 2026-05-23 -> 2026-10-19 2026-06-09
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-15
Trial Details
NCT Number NCT07448155
Lead Sponsor Incyte Corporation
Conditions Healthy Participants
Enrollment 126 participants
Start Date 2026-03-19
Primary Completion 2026-10-19 (estimated)
Study Completion 2026-10-19 (estimated)
Updated on ClinicalTrials.gov 2026-07-08